Human Induced Pluripotent Stem Cell-Derived Vascular Cells: Recent Progress and Future Directions

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Stem Cell Biology

Background:

• Human induced pluripotent stem cells (hiPSCs) offer potential for cardiovascular regeneration.
• Differentiating hiPSCs into vascular cells, including endothelial cells (ECs) and smooth muscle cells (SMCs), is crucial for therapeutic applications.
• While hiPSC-derived ECs show promise in neovascularization, hiPSC-derived SMCs are less explored for cardiovascular repair.

Purpose of the Study:

• To review methodologies for deriving vascular cells from hiPSCs.
• To propose a standardized framework for assessing vascular cell identity for tissue repair.
• To highlight the regenerative potential of hiPSC-derived vascular cells in preclinical models.

Main Methods:

• Review of existing literature on hiPSC differentiation into vascular cells.
• Emphasis on key developmental signals guiding cell fate.
• Analysis of preclinical studies using hiPSC-derived vascular cells in myocardial infarction and hindlimb ischemia models.

Main Results:

• hiPSC-derived ECs demonstrate robust potential for neovascularization in animal models.
• hiPSC-derived SMCs are emerging as a promising cell type for cardiovascular regeneration.
• Preclinical studies show regenerative effects of hiPSC-derived vascular cells in models of ischemic injury.

Conclusions:

• Standardized methods for vascular cell derivation and characterization from hiPSCs are needed.
• Overcoming current obstacles is essential for clinical translation of hiPSC-based cardiovascular therapies.
• hiPSC-derived vascular cells hold significant promise for treating cardiovascular diseases.